We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Lymphocytic Herpesviruses and Cerebrospinal Fluid Polymerase Chain Reaction (PCR)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2011 by Laura Kupila, PaijatHame Central Hospital.
Recruitment status was:  Not yet recruiting
ClinicalTrials.gov Identifier:
First Posted: September 22, 2011
Last Update Posted: September 22, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
University of Turku
Information provided by (Responsible Party):
Laura Kupila, PaijatHame Central Hospital

Enterovirus and herpes simplex viruses 1 and 2 are the main causative agents of central nervous system infections.

Instead, the role of lymphocytic herpesviruses in the etiology of central nervous system (CNS) infections is not clear, even if there is the positive cerebrospinal fluid (CSF) polymerase chain reaction (PCR)-result for the virus.

The aim of this study is to evaluate the presence of DNA from lymphocytic herpesviruses in the CSF obtained from the immunocompetent patients with CSF pleocytosis and from the patients with normal CSF leukocyte count.

Central Nervous System Infection

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Molecular Methods in the Etiological Diagnostics of Acute Central Nervous System Infections: Lymphocytic Herpesviruses and PCR

Further study details as provided by Laura Kupila, PaijatHame Central Hospital:

Biospecimen Retention:   Samples With DNA
CSF white cells + CSF supernatant, Blood white cells and serum

Estimated Enrollment: 60
Study Start Date: October 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
pleocytosis group
40 patients with clinical signs of CNS infection and having CSF pleocytosis.
non-pleocytosis group
20 patients not having CNS infection clinically and not having CSF pleocytosis.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   16 Years to 80 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Residents of the district of Paijat-Hame (200 000 inhabitants).

Inclusion Criteria:

  • Immunocompetent patients with clinical symptoms and signs of central nervous system infections and CSF pleocytosis (pleocytosis group)
  • Immunocompetent patients without suspicion of CNS infection and no CSF pleocytosis (non-pleocytosis group)

Exclusion Criteria:

  • Suspicion of CNS-infection, eg. encephalitis, but no CSF leukocytosis (pleocytosis group)
  • Patients without symptoms of CNS infection, but who has CSF pleocytosis of unknown origin (non-pleocytosis group)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01438879

Contact: Laura MA Kupila +358447195940 laura.kupila@phsotey.fi

PaijatHame Central Hospital Not yet recruiting
Lahti, Finland, 15850
Contact: Laura Kupila       laura.kupila@phsotey.fi   
Principal Investigator: Laura Kupila         
Sponsors and Collaborators
PaijatHame Central Hospital
University of Turku
Principal Investigator: Laura MA Kupila PaijatHame Central Hospital
  More Information

Responsible Party: Laura Kupila, Specialist in neurology, MD PhD, PaijatHame Central Hospital
ClinicalTrials.gov Identifier: NCT01438879     History of Changes
Other Study ID Numbers: R11077
First Submitted: September 20, 2011
First Posted: September 22, 2011
Last Update Posted: September 22, 2011
Last Verified: September 2011

Keywords provided by Laura Kupila, PaijatHame Central Hospital:
lymphocytic herpesvirus

Additional relevant MeSH terms:
Central Nervous System Infections
Central Nervous System Diseases
Nervous System Diseases